alexa
ISSN: 2168-9849
Cloning & Transgenesis
Make the best use of Scientific Research and information from our 700+ peer reviewed, Open Access Journals that operates with the help of 50,000+ Editorial Board Members and esteemed reviewers and 1000+ Scientific associations in Medical, Clinical, Pharmaceutical, Engineering, Technology and Management Fields.
Meet Inspiring Speakers and Experts at our 3000+ Global Conferenceseries Events with over 600+ Conferences, 1200+ Symposiums and 1200+ Workshops on
Medical, Pharma, Engineering, Science, Technology and Business

Cloning ’ s Promise

Rasha Shammas, Elizabeth A Perry and George Perry*
University of Texas at San Antonio, San Antonio, Texas, USA
Corresponding Author : George Perry
University of Texas at San Antonio
San Antonio, Texas, USA
E-mail: perry2500@sbcglobal.net
Received May 22, 2013; Accepted May 25, 2013; Published May 28, 2013
Citation: Shammas R, Perry EA, Perry G (2013) Cloning’s Promise. Clon Transgen 2: 109. doi:10.4172/2168-9849.1000109
Copyright: © 2013 Shammas R, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

Visit for more related articles at Cloning & Transgenesis

Over the past century, medicine has conquered infectious diseases in the developed world while more effective delivery systems continue to transform health in the developing world. Instead of half the population dying in childhood, we have now crafted life expectancy with death nearer to maximal lifespan and thus succumb to degenerative conditions of aging. In contrast to infectious disease treatment, medicine has only addressed the outcomes of degenerative conditions in order to provide therapy but not cures, leading to continued medical interventions without fundamentally understanding the nature of age dependent decline. The imperative is to provide more effective treatment for diabetes, Alzheimer’s and other diseases responsible for the majority of adult morbidity and mortality and can improve the quality of life for an aging population.
Cloning offers the hope of renewing function without complete understanding of the fundamental basis for decline. Either replacing non-functional cells or maintaining them through support cells is being actively explored. These approaches are still evolving due to mechanistic understanding, e.g. the benefits of dopaminergic treatment for Parkinson’s disease are achieved through maintaining the function of the neuron rather than the transplant.
Further work to minimize the risk of stem cell derived tumors is essential. An even more promising work is shown with drugs that can increase renewal of the adult stem cells and solve the issue of rejection and limited cell sources. Future work to maximize safety as well as address the ethics of changing survival curves will make the intellectual hot bed of biomedical research for decades to follow.
Select your language of interest to view the total content in your interested language
Post your comment

Share This Article

Relevant Topics

Recommended Conferences

Article Usage

  • Total views: 11340
  • [From(publication date):
    August-2013 - Dec 07, 2016]
  • Breakdown by view type
  • HTML page views : 7606
  • PDF downloads :3734
 
 

Post your comment

captcha   Reload  Can't read the image? click here to refresh

OMICS International Journals
 
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
 
 
OMICS International Conferences 2016-17
 
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings
 
 

Contact Us

Agri, Food, Aqua and Veterinary Science Journals

Dr. Krish

agrifoodaquavet@omicsonline.com

1-702-714-7001 Extn: 9040

Clinical and Biochemistry Journals

Datta A

clinical_biochem@omicsonline.com

1-702-714-7001Extn: 9037

Business & Management Journals

Ronald

business@omicsonline.com

1-702-714-7001Extn: 9042

Chemical Engineering and Chemistry Journals

Gabriel Shaw

chemicaleng_chemistry@omicsonline.com

1-702-714-7001 Extn: 9040

Earth & Environmental Sciences

Katie Wilson

environmentalsci@omicsonline.com

1-702-714-7001Extn: 9042

Engineering Journals

James Franklin

engineering@omicsonline.com

1-702-714-7001Extn: 9042

General Science and Health care Journals

Andrea Jason

generalsci_healthcare@omicsonline.com

1-702-714-7001Extn: 9043

Genetics and Molecular Biology Journals

Anna Melissa

genetics_molbio@omicsonline.com

1-702-714-7001 Extn: 9006

Immunology & Microbiology Journals

David Gorantl

immuno_microbio@omicsonline.com

1-702-714-7001Extn: 9014

Informatics Journals

Stephanie Skinner

omics@omicsonline.com

1-702-714-7001Extn: 9039

Material Sciences Journals

Rachle Green

materialsci@omicsonline.com

1-702-714-7001Extn: 9039

Mathematics and Physics Journals

Jim Willison

mathematics_physics@omicsonline.com

1-702-714-7001 Extn: 9042

Medical Journals

Nimmi Anna

medical@omicsonline.com

1-702-714-7001 Extn: 9038

Neuroscience & Psychology Journals

Nathan T

neuro_psychology@omicsonline.com

1-702-714-7001Extn: 9041

Pharmaceutical Sciences Journals

John Behannon

pharma@omicsonline.com

1-702-714-7001Extn: 9007

Social & Political Science Journals

Steve Harry

social_politicalsci@omicsonline.com

1-702-714-7001 Extn: 9042

 
© 2008-2016 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version